Lisdexamfetamine Dimesylate | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lisdexamfetamine Dimesylate
FDA Orange Book

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Lisdexamfetamine Dimesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 2 EU WC, 10 NDC API, 13 Listed Suppliers, $ API Reference Price

21 API Suppliers
10 USDMF
2 EU WC
10 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

239 FDF Dossiers, 133 FDA Orange Book, 58 Europe, 32 Canada, 6 Australia, 3 South Africa, 7 Listed Dossiers

239 FDF Dossiers
133 FDA Orange Book
58 Europe
32 Canada
6 Australia
3 South Africa
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 20MG, CAPSULE;ORAL - 30MG, CAPSULE;ORAL - 40MG, CAPSULE;ORAL - 50MG, CAPSULE;ORAL - 60MG, CAPSULE;ORAL - 70MG

CAPSULE;ORAL - 10MG
CAPSULE;ORAL - 20MG
CAPSULE;ORAL - 30MG
CAPSULE;ORAL - 40MG
CAPSULE;ORAL - 50MG
CAPSULE;ORAL - 60MG
CAPSULE;ORAL - 70MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 8 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 8 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Bioplus Life Sciences, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 5 Kerry, 3 Lonza Capsugel, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 13 Roquette, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Vasa Pharmachem

2 Rochem International Inc
13 SPI Pharma
8 DKSH
1 Jai Radhe Sales
1 Pharm-RX Chemical
4 Faran Shimi Pharmaceutical
8 Gangwal Healthcare
1 Pfanstiehl
4 ACG Worldwide
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
1 Bioplus Life Sciences
3 DFE Pharma
5 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
5 Kerry
3 Lonza Capsugel
9 Microlex e.U
1 Pharmatrans-Sanaq
4 Pluviaendo
3 Prachin Chemical
1 Qualicaps
13 Roquette
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
9 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 22 Direct Compression, 16 Thickeners and Stabilizers, 14 Disintegrants & Superdisintegrants, 13 Taste Masking, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 10 Granulation, 8 Empty Capsules, 7 Coating Systems & Additives, 4 Controlled & Modified Release, 4 Parenteral, 3 Coloring Agents, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Rheology Modifiers

42 Fillers, Diluents & Binders
22 Direct Compression
16 Thickeners and Stabilizers
14 Disintegrants & Superdisintegrants
13 Taste Masking
12 Co-Processed Excipients
11 Lubricants & Glidants
11 Chewable & Orodispersible Aids
10 Granulation
8 Empty Capsules
7 Coating Systems & Additives
4 Controlled & Modified Release
4 Parenteral
3 Coloring Agents
3 Emulsifying Agents
3 Film Formers & Plasticizers
2 API Stability Enhancers
2 Rheology Modifiers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 39 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
39 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 55 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
55 Finished Drug Prices
10 Annual Reports

MARKET PLACE

9 APIs, 3 FDF Dossiers

9 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

$ API Ref.Price (USD/KG) : 3,809 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

133 All

01 7ACTAVIS ELIZABETH

02 7ALKEM LABS LTD

03 6AMNEAL

04 7APOTEX

05 13ASCENT PHARMS INC

06 7HIKMA

07 7LANNETT CO INC

08 6MSN

09 7MYLAN

10 7NORWICH

11 7PRINSTON INC

12 7RHODES PHARMS

13 6SANDOZ

14 7SPECGX LLC

15 13SUN PHARM INDS INC

16 13TAKEDA PHARMS USA

17 6TEVA PHARMS

filter Dosage Reset all filters

133 All

01 103CAPSULE;ORAL

02 30TABLET, CHEWABLE;ORAL

filter Regulatory Info Reset all filters

133 All

01 13DISCN

02 120RX

filter Brand Name Reset all filters

133 All

01 120LISDEXAMFETAMINE DIMESYLATE

02 13VYVANSE

filter RLD Reset all filters

133 All

01 120No

02 13Yes

Lisdexamfetamine Dimesylate

List of Suppliers

Product Main Page

01

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

LISDEXAMFETAMINE DIMESYLATE

Brand Name : LISDEXAMFETAMINE DIMESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 10MG

Approval Date : 2023-08-25

Application Number : 202802

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

LISDEXAMFETAMINE DIMESYLATE

Brand Name : LISDEXAMFETAMINE DIMESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Approval Date : 2023-08-25

Application Number : 202802

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

ACTAVIS ELIZABETH

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

LISDEXAMFETAMINE DIMESYLATE

Brand Name : LISDEXAMFETAMINE DIMESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Approval Date : 2023-08-25

Application Number : 202802

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 30MG

Approval Date : 2007-02-23

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

05

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Approval Date : 2007-02-23

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

06

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 70MG

Approval Date : 2007-02-23

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

07

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 20MG

Approval Date : 2007-12-10

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

08

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Approval Date : 2007-12-10

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

09

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 60MG

Approval Date : 2007-12-10

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

10

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

TAKEDA PHARMS USA

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LISDEXAMFETAMINE DIMESYLATE

Brand Name : VYVANSE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 10MG

Approval Date : 2014-10-30

Application Number : 21977

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?